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Abstract
Glycolysis is a metabolic pathway that is central to the assimilation of carbon for either respiration or fermentation and
therefore is critical for the growth of all organisms. Consequently, glycolytic transcriptional regulation is important for the
metabolic flexibility of pathogens in their attempts to colonize diverse niches. We investigated the transcriptional control of
carbohydrate metabolism in the human fungal pathogen Candida albicans and identified two factors, Tye7p and Gal4p, as
key regulators of glycolysis. When respiration was inhibited or oxygen was limited, a gal4tye7 C. albicans strain showed a
severe growth defect when cultured on glucose, fructose or mannose as carbon sources. The gal4tye7 strain displayed
attenuated virulence in both Galleria and mouse models as well, supporting the connection between pathogenicity and
metabolism. Chromatin immunoprecipitation coupled with microarray analysis (ChIP-CHIP) and transcription profiling
revealed that Tye7p bound the promoter sequences of the glycolytic genes and activated their expression during growth
on either fermentable or non-fermentable carbon sources. Gal4p also bound the glycolytic promoter sequences and
activated the genes although to a lesser extent than Tye7p. Intriguingly, binding and activation by Gal4p was carbon
source-dependent and much stronger during growth on media containing fermentable sugars than on glycerol.
Furthermore, Tye7p and Gal4p were responsible for the complete induction of the glycolytic genes under hypoxic growth
conditions. Tye7p and Gal4p also regulated unique sets of carbohydrate metabolic genes; Tye7p bound and activated genes
involved in trehalose, glycogen, and glycerol metabolism, while Gal4p regulated the pyruvate dehydrogenase complex. This
suggests that Tye7p represents the key transcriptional regulator of carbohydrate metabolism in C. albicans and Gal4p
provides a carbon source-dependent fine-tuning of gene expression while regulating the metabolic flux between
respiration and fermentation pathways.
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Introduction
In order to grow and thrive in a wide range of hosts, pathogens
not only depend on certain virulence factors but also metabolic
flexibility; therefore, they must be able to assimilate various carbon
sources. Carbohydrates are the primary and preferred source of
metabolic carbon for most organisms, and are used for generating
energy and producing biomolecules. Most sugars are converted to
glucose 6-phosphate or fructose 6-phosphate before entering the
glycolytic pathway. Glycolysis is then responsible for converting
these hexose phosphates into the key metabolite pyruvate while
producing ATP and NADH (Figure 1). From there, cells carry out
two major strategies of energy production: fermentation and
respiration. Although both processes regenerate NAD+, respira-
tion is significantly more energetically efficient than fermentation
as it produces additional ATP through the tricarboxylic acid
(TCA) cycle and oxidative phosphorylation. However, regardless
of the mode of energy production, glycolysis is the central,
common pathway for both processes. As glycolysis is critical for
carbon assimilation, the pathway has been shown to be up-
regulated during infections and important to the virulence in
pathogenic bacteria, parasites, and fungi [1–6].
Since glycolysis is a central metabolic pathway, it is strictly
regulated. While there are different levels of regulation of the
process, transcriptional control is common to bacteria, fungi,
plants, and animals. The glycolytic enzymes are transcriptionally
regulated in response to environmental conditions such as oxygen
levels, carbon source and availability, and to cellular demands
such as metabolite concentrations and energy needs. However, in
most species the regulators of glycolytic gene expression have not
been identified, so our understanding of transcriptional control of
glycolysis in eukaryotes is mainly based on the non-pathogenic
yeast Saccharomyces cerevisiae (for review see [7]). In S. cerevisiae, the
transcription regulators Gcr1p and Gcr2p are primarily respon-
sible for activating the expression of the glycolytic genes [8,9].
Gcr1p binds to CT boxes (59-CTTCC-39) upstream of the
glycolytic genes and Gcr2p acts as a co-activator by forming a
complex with Gcr1p [10,11]. Deleting either gene decreases the
PLoS Pathogens | www.plospathogens.org 1 October 2009 | Volume 5 | Issue 10 | e1000612expression levels of the glycolytic genes resulting in growth defects
during culture on glucose [9,12]. However, the mutant strains
display wild type growth rates on non-fermentable carbon sources
[9,12]. The factor Tye7p (also referred to as Sgc1p) is another
glycolysis-specific regulator in S. cerevisiae. Tye7p has been shown
to be involved in the activation of several glycolytic genes,
although not to the same extent as Gcr1p and Gcr2p [13]. This
activation is independent of GCR1 and the tye7 strain displays no
growth defects under any carbon source regime [13,14]. The
transcription factors Rap1p, Abf1p, and Reb1p also have roles in
activating the glycolytic genes, but these are global factors involved
in many cellular processes [15–18].
Although the glycolytic circuit is well characterized in S.
cerevisiae, most organisms to do not have GCR1 or GCR2 homologs
[19]. Furthermore, it is well established that the Saccharomyces-
lineage exhibits a unique dependence on the fermentation
pathway: these yeasts mainly ferment sugars to ethanol instead
of using respiration, even under aerobic conditions [20]. S. cerevisiae
up-regulates glycolysis and represses the TCA cycle in the
presence of glucose allowing this aerobic fermentation behavior
to occur [21]. Only when no fermentable carbon sources are
present, after the post-diauxic shift, will S. cerevisiae switch to the
respiratory mode. This phenomenon is known as the Crabtree
effect and is due to a glucose repression circuit that is largely
regulated by the transcriptional repressors Mig1p and Rgt1p, the
protein kinase Snf1p, and the protein complex SCF
Grr1 [20]. This
regulatory circuit is proposed to have developed from the adaptive
potential derived from the whole-genome duplication that
occurred after the divergence of Saccharomyces from Kluyveromyces
[22,23]; the repression circuit is common to the Saccharomyces-
lineage and many of the genes retained from the whole-genome
duplication are involved in the lifestyle adaptation to aerobic
ethanol production [24–26].
The facultative anaerobic lifestyle of Crabtree-positive Saccha-
romyces yeasts is in contrast to that of most other eukaryotes, which
are either facultative or obligate aerobes and lack the glucose
repression circuit. Under aerobic conditions, Crabtree-negative
cells predominately oxidize pyruvate to carbon dioxide through
the TCA cycle. In the absence of oxygen, most aerobic organisms
are able to utilize the fermentation pathway to some extent to
continue regenerating NAD+. This difference in metabolic flux is
highlighted by transcription profiles of the aerobic fungi
Trichoderma reesei, Neurospora crassa, and Aspergillus oryzae, which
show little or no repression of the TCA cycle in glucose rich
compared to glucose poor growth conditions, and therefore do not
rely as heavily on the fermentation pathway as does S. cerevisiae
[27–29].
The opportunistic human fungal pathogen Candida albicans is a
facultative aerobe and thus metabolizes carbon sources in response
to oxygen availability similar to that of a typical eukaryotic cell. C.
albicans is responsible for various non life-threatening infections
such as oral thrush and vaginitis but in extreme cases, especially in
immunosuppressed individuals, it can cause potentially lethal
systemic infections. In fact, Candida species are the most common
isolated agent in fungal infections and the fourth leading cause of
nosocomial bloodstream infections in the United States, with an
attributable mortality rate of approximately 38–49% and
treatment costs estimated to be $1.7 billion annually [30–33]. C.
albicans accounts for more than half of all Candida infections
[30,33], highlighting the importance of understanding the
metabolism of this pathogen for the development of effective
antifungal treatments.
Crabtree-negative organisms that lack GCR1/2 homologs, such
as C. albicans, must control transcription of glycolytic genes
differently than does S. cerevisiae. In this study, we characterized
two fungal-specific activators of the glycolytic pathway in C.
albicans, Tye7p and Gal4p. Deleting both genes resulted in severe
growth defects when the mutant cells were cultured on
fermentable carbon sources when respiration was inhibited or
oxygen was limited, and chromatin immunoprecipitation coupled
with microarray analysis (ChIP-CHIP) and transcription profiling
showed these factors bind to and regulate expression of the
glycolytic pathway genes. Tye7p and Gal4p are also required for
complete pathogenicity as the mutant strains showed attenuated
virulence. This work therefore defines the key regulatory elements
controlling glycolytic gene expression in a facultative aerobic
pathogen.
Results
Deletion of CaGAL4 and CaTYE7 results in a severe
growth defect on fermentable carbon sources when the
respiration pathway is disrupted
We investigated possible transcriptional regulators of glycolytic
gene expression in C. albicans. In the well-studied yeast S. cerevisiae,
Gcr1p, Gcr2p, and Tye7p are key glycolysis-specific activators.
Unlike Gcr1p and Gcr2p, which are limited to Saccharomyces and
closely related yeasts, Tye7-like transcription factors can be found
throughout the Saccharomycotina subphylum. Therefore, while
there are no homologs of Gcr1p or Gcr2p in C. albicans, there is a
CaTye7p. ScTye7p and CaTye7p share 87% amino acid
similarity in the DNA binding basic-helix-loop-helix (bHLH)
domain but only 33% in the activation domain. A recent
investigation also implicated the CaGal4p transcription regulator
in the expression of genes involved in glycolysis [34]; while Gal4p
in S. cerevisiae is a well-characterized zinc cluster transcription
factor that regulates galactose catabolism, it does not fulfill this role
in C. albicans. ScGal4p and CaGal4p also share homology strictly
in the DNA-binding domain. Due to the potential or observed
involvement of these factors in aspects of carbohydrate metabo-
lism, we tested the role of CaTye7p and CaGal4p in the control of
glycolytic gene expression in C. albicans.
Author Summary
Pathogens must be able to assimilate the carbon sources
in their environment to generate sufficient energy and
metabolites to survive. Since glycolysis is a central
metabolic pathway, it is important for this metabolic
flexibility. The most commonly isolated agent in human
fungal infections, Candida albicans, depends upon glycol-
ysis for the progression of systemic disease. We investi-
gated glycolytic transcriptional regulation in C. albicans
and defined two key regulators of the pathway, Tye7p and
Gal4p. We demonstrated that these factors are important
for the fermentative growth of C. albicans both in vitro and
in vivo and also regulate the input and output fluxes of
glycolysis. The gal4tye7 strain showed attenuated virulence
in a Galleria and two mouse models, potentially due to the
severe growth defect in oxygen-limiting environments.
Gal4p and Tye7p represent fungal specific regulators
involved in the pathogenicity of the organism that may
be exploited in the development of antifungal treatments.
Our study describes a fungal glycolytic transcriptional
circuit that is fundamentally different from that of the
model yeast Saccharomyces cerevisiae, providing further
evidence that the transcriptional networks in S. cerevisiae
need not be generally representative of the fungal
kingdom.
Carbohydrate Regulation in Candida albicans
PLoS Pathogens | www.plospathogens.org 2 October 2009 | Volume 5 | Issue 10 | e1000612Figure 1. An overview of the central metabolic pathways in yeast. The enzyme names are for C. albicans but some have not been directly
characterized and are annotated based on S. cerevisiae homology. Genes bound and activated by Gal4p and Tye7p are in red, genes bound and
activated mainly by Tye7p are in blue, and genes bound and activated mainly by Gal4p are in green. Genes in black are not bound and activated by
either factor. For simplicity, ‘‘*’’ represents reactions requiring ATP, ‘‘**’’ represents reactions producing ATP, and ‘‘***’’ represents reactions
generating NADH. These symbols are given for reactions of the glycolytic pathway only.
doi:10.1371/journal.ppat.1000612.g001
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conjunction with our previously generated gal4 strain [34]. We
tested the ability of all strains to grow on the fermentable carbon
sources glucose, fructose, mannose, and galactose, and the non-
fermentable carbon source glycerol. On solid media, no growth
defect was evident for any deletion strain regardless of the carbon
source or concentration tested (Figure 2A). However, when the
more sensitive liquid assay was used with glucose, galactose, and
glycerol carbon sources, it was able to identify a minor growth
defect for the gal4tye7 strain with glucose media, as the doubling
time was 147 min compared to that of the wild type of 123 min
(Table 1 and Figure S1A). As C. albicans lacks the glucose
repression mechanism that exists in S. cerevisiae, its respiration
pathway is active under glucose growth conditions so it is not
critically dependent on the glycolytic pathway. Although glycolysis
is central to both the respiration and fermentation pathways, it is
more important for fermentative metabolism since under these
conditions the cell must rely exclusively on the ATP generated by
glycolysis. As a result, glycolysis proceeds at a higher rate in
fermenting cells [20].
To mimic the fermentative metabolism of S. cerevisiae, the
mitochondrial inhibitor antimycin A was added to the solid media,
and cells in liquid culture were grown without aeration. These
changes disrupt the proton gradient and ultimately prevent the
Figure 2. GAL4 and TYE7 are involved in fermentative growth with glucose, fructose or mannose as the sole carbon source. WT refers
to strain CMM1. Cells were serially diluted and a representative dilution is displayed. Pictures were taken from plates where the carbon source was at
2% although the 0.2% plates gave similar results. (A) Solid media without antimycin A. Pictures were taken after 2–3 days of growth. (B) Solid media
with antimycin A (2 mg/ml). Pictures were taken after 2–3 days of growth except for galactose (6 days).
doi:10.1371/journal.ppat.1000612.g002
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respiration pathway. When C. albicans was forced to use
fermentation, a severe growth defect during culture on glucose,
fructose or mannose media was evident for the double mutant
strain (Figures 2B and S1B and Table 1). Therefore, it appears that
both Gal4p and Tye7p are involved in fermentative growth with
most fermentable carbon sources. The tye7 strain showed a minor
growth defect under these fermentative conditions while the gal4
strain still grew at wild type levels, suggesting that Tye7p is a more
important regulator of fermentative growth. This prediction was
supported by the complemented strains, as reintroducing one copy
of TYE7 was sufficient to restore wild type growth rates to the
double mutant strain, while one copy of GAL4 resulted in only
partial restoration (Figure S1B). Therefore, although both factors
appear to be involved in regulating the fermentative growth
pathway, Tye7p plays a more central role.
Galactose was unique among the fermentable carbon sources
tested as no distinct phenotype was observed for the gal4tye7 strain
compared to the wild type under fermentative growth conditions
(Figures 2B and S1B). This is likely due to the Kluyver effect,
which is thought to be a result of insufficient sugar uptake, and
prevents the growth on certain sugars in the absence of respiration
[35]. The fermentative growth conditions used (growth without
aeration and antimycin A at 2 mg/ml) do not completely inhibit
respiration, which allowed the strains to grow, although very
slowly, in galactose media. Most yeast hexose transporters are able
to take up glucose, fructose, and mannose, while galactose uptake
requires separate transporters. If galactose uptake is the limiting
step, then any effect of GAL4 or TYE7 on the fermentation
pathway will be minimized. Therefore, the lack of observed
difference between the mutant strain and the wild type in
Figures 2B and S1B is not because the gal4tye7 strain grows well
on galactose media when respiration is disrupted, but instead is a
result of the comparably poor growth of the wild type strain (Table
S1).
Location profiling reveals that Gal4p and Tye7p bind
many carbohydrate metabolic promoter targets
To gain insight into why Gal4p and Tye7p are required for
fermentative growth, we performed ChIP-CHIP to determine
their binding targets. ChIP-CHIP of chromosomally TAP-tagged
Gal4p and Tye7p was first performed during growth in glucose
media since glucose is the primary carbon source that stimulates
the glycolytic pathway. Two different microarray formats, single
spot full-genome arrays and whole-genome tiling arrays, were used
to provide different strategies for data analysis and for validation
purposes. Gal4p bound 98 targets and Tye7p bound 271 targets
with the single probe full-genome array (Tables S2 and S3), so
Tye7p appears to function as a more global regulator. However,
both gene sets were significantly enriched for glucose/carbohy-
drate metabolic processes and both factors bound essentially all the
glycolytic genes. The Gene Ontology (GO) biological processes
that were enriched in the bound-gene sets are displayed in
Figure 3A. The results are similar between the two factors except,
as is discussed below, Gal4p bound more targets involved in
pyruvate metabolism. Although Tye7p bound a large number of
targets, no GO process is enriched other than carbon metabolism.
The tiling array showed highly similar results but was able to
identify a few additional targets including three glycolytic genes,
PFK26-2, GLK1, and GLK4. Smoothed peak intensity curves of the
tiling array binding events were created to estimate the largest fold
enrichments and thus the most significant targets. For Gal4p, the
13 bona fide glycolytic pathway promoters are in the top 68
smoothed peak intensities while for Tye7p they are in the top 52
peaks (Tables S4 and S5). Therefore, the glycolytic promoters are
among the most significant targets for both factors. As well, several
genes involved in ethanol fermentation (PDC11, ADH1, and
NDE1) are included in this group of targets. Therefore, the ChIP-
CHIP data suggests that Gal4p and Tye7p are involved in the
entire fermentation pathway from glucose to ethanol.
Although Gal4p and Tye7p bound many common targets, there
were a significant number of individual binding events, some of
which are related to carbohydrate metabolism (Figure 3B). The
clearest example is that Gal4p bound the promoter sequences of
the five genes encoding the pyruvate dehydrogenase complex
(PDH) while Tye7p bound the promoter sequences of the three
genes for the trehalose synthase complex. Tye7p also bound
several genes involved in glycogen and glycerol metabolism. A
summary of selected metabolic binding targets under glucose
growth conditions is shown in Figure 4A and Table S6. Many of
the Gal4p and Tye7p targets are linked to the glycolytic pathway
suggesting that these factors also regulate the input and output
fluxes of the pathway.
Both Gal4p and Tye7p activate genes required for
fermentative growth
ChIP-CHIP is a whole-genome approach for determining
binding locations of a transcription factor; however, it is
insufficient to give a complete picture of a factor’s biological
function. As was observed with GAL4, the binding and
transcription profiles can provide different insights. Therefore, to
complement the ChIP-CHIP analysis, transcription profiling
comparing wild type and mutant strains was performed under
glucose growth conditions. The expression levels of selected
carbohydrate metabolic genes is illustrated in Figure 4B and Table
S7. As expected, not all targets bound by ChIP-CHIP showed
differential expression and not all differentially regulated genes
showed direct binding of the transcription factors; however, in
general the most significantly bound targets were down-regulated
in the absence of the factor. The glycolytic and fermentation genes
were down-regulated in the tye7 strain confirming Tye7p’s role as
an activator of fermentative metabolism. Gal4p is also involved in
the activation of the glycolytic/fermentation genes because the
expression levels of these genes were lower in the gal4tye7 strain
compared to the tye7 strain. The involvement of Gal4p in the
activation of glycolytic gene expression was masked in the gal4
expression profiles, most likely because the absence of GAL4
caused an up-regulation of TYE7 [34]. Therefore, Tye7p appears
able to significantly compensate for the loss of Gal4p, further
supporting the idea that it plays a more central role in glycolytic
gene regulation than does Gal4p.
Table 1. Doubling times under glucose growth conditions.







Doubling times of the strains for the glucose growth curves in Figure S1. The
natural log of the OD600 was plotted versus time and the best-fit line of the
exponential phase was determined. The doubling time was equal to ln2/slope.
doi:10.1371/journal.ppat.1000612.t001
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involved in trehalose metabolism. Expression of the trehalose
metabolic genes was down-regulated in the tye7 strain but not
further reduced in the gal4tye7 strain indicating that Gal4p is not
involved in their activation. Trehalose is a glucose disaccharide that
has a role as a storage carbohydrate in yeast. Another important
storage molecule in yeast is glycogen. Tye7p also bound several
glycogen metabolic targets (GPH1, GDB1, GLG1, GSY1, and GLC3)
thatweresubsequentlydown-regulatedinthetye7strainandshowed
no influence of Gal4p in the gal4tye7 strain. As well, Tye7p was the
sole regulator of several glycerol metabolic targets (DAK2, GCY1,
GPP1, GPD1,a n dGPD2). On the other hand, Gal4p activated the
PDH genes with no influence from Tye7p. These genes were not
down-regulated in the tye7 strain (some were slightly up-regulated
along with GAL4) but were reduced in the gal4tye7 strain.
The down-regulated genes were analyzed for GO enrichment.
As expected, all the categories were related to carbon metabolism.
Generally, the two deletion strains had similar results with
glycolysis (tye7 P-value: 1.34E-18; gal4tye7: 1.44E-15) and cellular
alcohol metabolic process (tye7: 4.48E-17; gal4tye7: 8.33E-16) being
the most significantly enriched categories.
Tye7p regulates the cell’s commitment to glycolysis
Tye7p directly activated many genes involved in trehalose and
glycogen metabolism independently of Gal4p. As well, the genes
encoding the glycolytic-committing enzyme phosphofructokinase
(PFK1 and PFK2) were among the top six most down-regulated
genes in the tye7 strain while the gluconeogenesis-specific gene FBP1
was moderately down-regulated. Therefore, it appears that Tye7p
regulates the flux between energy storage and energy production at
the glucose-6-phosphate branch point (Figure 1). To support this
claim, we investigated whether the levels of trehalose and glycogen
were different in the tye7 strain compared to the wild type. Since
exponentially growing cells have low trehalose levels that rapidly
Figure 3. Gal4p and Tye7p bind many carbohydrate metabolic promoter targets under glucose growth conditions. (A) GO enrichment
of YPD binding targets for Gal4p and Tye7p. Targets with a normalized fold enrichment .1.5 and a P-value,0.1 with the single spot full-genome
microarray (98 and 271 genes for Gal4p and Tye7p, respectively) were analyzed with the CGD GO Term Finder (http://www.candidagenome.org/cgi-
bin/GO/goTermFinder). The P-value of enrichment for each GO category is indicated. (B) Overlap of YPD binding targets from (A). The common
targets are highly enriched for glycolysis genes. The Gal4p independent targets include the five components of the PDH while the Tye7p
independent targets contain the three components of the trehalose synthase complex.
doi:10.1371/journal.ppat.1000612.g003
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determined from cells at both phases. We observed significantly
increased levels of trehalose in the tye7 strain for both stationary and
logarithmic phase cells (Figure 5A). Additionally, iodine staining
showed that the glycogen content in the tye7 cells was higher than
that of the wild type (Figure 5B). The higher storage carbohydrate
levels correlate with the expression profile as FBP1 and the majority
of genes involved in trehalose and glycogen metabolism were down-
regulated 2–3 fold while PFK1 and PFK2 were down-regulated
approximately 6 and 9 fold, respectively. Therefore, the glucose-6-
phosphate flux in the tye7 strain would favor trehalose and glycogen
synthesis. In contrast, the gal4 strain showed wild type levels of both
storage carbohydrates, suggesting that Tye7p alone regulates the
cell’s decision to commit to glycolysis or energy storage.
Figure 4. Gal4p and Tye7p bind to and regulate the expression of genes involved in the fermentation pathway under glucose
growth conditions. Heat map displays of the ChIP-CHIP and expression profiles were created with the Cluster and TreeView programs (http://rana.
lbl.gov/EisenSoftware.htm). (A) Tye7p and Gal4p ChIP-CHIP binding profiles of selected metabolic targets with the single spot full-genome
microarray. Fold enrichments displayed represent the intergenic probe for the respective gene and enrichments ,1.0 were adjusted to 1.0 for
graphical purposes. Black represents no binding while red represents binding with the color brightness indicating the degree of enrichment. Binding
to the glycolytic genes was so strong that binding to two neighboring probes was sometimes observed. In such cases, both values were included as
these occurred in situations where a shared promoter region contained two probes but the tiling array confirmed the presence of a single binding
site. The fold enrichments of these and other metabolic targets are given in Table S6. (B) Transcription profile of selected metabolic genes for the tye7
and gal4tye7 strains. Black represents no change in expression, green is down-regulated, and red is up-regulated with the color brightness indicating
the degree of expression change. The expression levels of these and other metabolic genes are given in Table S7.
doi:10.1371/journal.ppat.1000612.g004
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source while Gal4p displays differential binding
It is clear that Gal4p and Tye7p are important for fermentative
growth when glucose, fructose or mannose is the carbon source.
Although there was no phenotype during growth on galactose or
glycerol, we investigated the effect of these carbon sources on
binding to identify any differences (Dataset S1). Figure 6A illustrates
the ChIP-CHIP results of selected carbohydrate metabolic targets
during growth on galactose and glycerol media with the behavior
during growth on glucose included as a comparison.
A striking trend was the difference in binding between Gal4p
and Tye7p under the various carbon sources. Whereas the peak
intensity of Gal4p binding changed based on the carbon source,
the peak sizes of Tye7p binding were largely unaffected
(Figure 7A). This pattern was consistent for the majority of targets
resulting in a decrease in the overall number of Gal4p binding
targets from glucose to galactose to glycerol and a similar overall
number of binding sites for Tye7p with the different carbon
sources (Figure S2). Therefore, Gal4p binds its few targets in a
carbon source-dependent manner while Tye7p appears to be a
more global regulator that binds its targets independently of the
carbon source the cells are growing on. This difference in target
binding dependent on the carbon source could be a direct result of
the protein levels of the transcription factors. We compared
protein levels during growth in YPD, YPGal, and YPGly media
relative to YP media and observed that Gal4p is significantly
induced by glucose while Tye7p has a more constitutive expression
(Figure S3). These results further support the inference that Tye7p
is the more central regulator of carbohydrate metabolism.
Another trend was that Gal4p showed stronger binding to the
promoters of genes encoding the glycolytic pathway enzymes that
acted in the later part of the pathway (from TPI1 on) compared to
the early part of the pathway, regardless of the carbon source of
the growth medium (Figure 6A). In Figure 7A, HXK2 binding is
representative of early pathway genes and PGK1 binding is
representative of later pathway genes. Interestingly, this difference
in binding within the pathway corresponds at the point where the
six carbon glucose molecule has been converted to two three
carbon products and also represents the separation between the
initial ATP consuming steps and the later energy producing steps
(Figure 1). Therefore, while Tye7p appears to be involved in
committing the cell to glycolysis, Gal4p appears to focus on the
later part of the pathway to promote energy production once the
commitment is made.
CaTye7p and CaGal4p bind to distinct motifs
The binding distribution curves created with the tiling array
were also used to predict the motif that CaGal4p and CaTye7p
recognize by looking for sequences enriched around the binding
sites of the top peak intensity targets. ScGal4p has a well
established 59-CGG(N11)CCG-39 motif [37]. Analysis of the top
CaGal4p binding targets revealed enrichment for this motif
(Figure 7B). Since ScGal4p and CaGal4p have 86% sequence
similarity in the DNA binding domain, it is reasonable to expect
they would recognize a similar sequence. The binding distribution
curves of HXK2, PGK1, and PDA1 showed Gal4p motifs near the
binding sites of CaGal4p (Figure 7A).
As previously mentioned, CaTye7p is a bHLH transcription
factor. These type of factors are known to recognize the E-box
sequence 59-CANNTG-39 [38]. The motif enriched among the top
CaTye7p binding targets contains this bHLH signature (Figure 7B).
The binding distribution curves of HXK2, PGK1,a n dTPS3 showed
Tye7p motifs near the binding sites of CaTye7p (Figure 7A).
Tye7p and Gal4p are carbon-source dependent
activators
To gain further insight into how Gal4p and Tye7p regulate
their targets in response to different carbon sources, transcription
Figure 5. Deletion of TYE7 results in higher trehalose and glycogen levels. (A) The trehalose content of wild type (BWP17), tye7, and gal4
cells at both stationary and logarithmic phases were measured. Trehalose levels (nmol trehalose per mg cell protein) were reported relative to the
wild type in stationary phase. Both wild type and gal4 cells had no detectable trehalose levels in the logarithmic phase and were not included in the
graph. (B) Wild type (BWP17), tye7, and gal4 cells were exposed to iodine vapor to indicate the glycogen content as iodine vapor stains cells brown
upon reacting with glycogen. The tye7 cells stained a darker brown than the wild type indicating that there is more glycogen present.
doi:10.1371/journal.ppat.1000612.g005
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and glycerol as the sole carbon source were performed. Figure 6B
illustrates the expression profiles of selected carbohydrate
metabolic targets during growth on galactose and glycerol media
with the behavior during growth on glucose included as a
comparison (complete lists of down-regulated genes in Tables S8,
S9, S10, S11, S12 and S13). The glycolytic genes were down-
regulated in the tye7 strain under galactose and glycerol growth
conditions but not as significantly as with glucose-containing
media. Gal4p strongly activated the glycolytic genes on glucose
and galactose media but had only minimal effect when glycerol
was the carbon source. This result correlates with the location
profiling data as Gal4p displayed reduced binding under glycerol
growth conditions. Tye7p and Gal4p’s carbon-source dependent
roles in glycolytic gene expression were validated by quantitative
real-time PCR (qPCR) (Figure S4).
Gal4p and Tye7p are involved in glycolytic gene
induction in hypoxic growth conditions
Pathogens must not only be adept at utilizing different carbon
sources but must also be able to handle changes in oxygen levels.
For C. albicans, this flexibility involves growth in oxygen rich
environments such as the skin and oral mucosal layers and oxygen
poor niches such as inner organs. Since serious systemic infections
Figure 6. Comparison of ChIP-CHIP and expression profiles with glucose, galactose, and glycerol media. Heat map displays were
created as described in Figure 4. (A) Tye7p and Gal4p ChIP-CHIP binding profiles of selected metabolic targets with the single probe full-genome
microarray. The fold enrichments of these and other metabolic targets are given in Table S6. (B) Transcription profiles of selected metabolic genes for
tye7 (1) and gal4tye7 (2) strains under glucose (Glu), galactose (Gal), and glycerol (Gly) carbon sources. The expression levels of these and other
metabolic genes are given in Table S7.
doi:10.1371/journal.ppat.1000612.g006
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to HXK2 (i), PGK1 (ii), PDA1 (iii), and TPS3 (iv) under glucose, galactose, and glycerol growth conditions with the tiling array. HXK2 and PGK1 represent
common glycolytic targets while PDA1 and TPS3 represent Gal4p and Tye7p specific targets, respectively. The ORF and 1500 bp upstream region is
shown. Values for each data point were determined by taking the mean fold enrichment of each probe and the surrounding four probes. The dashed
blue and green lines represent the Tye7p and Gal4p binding sites, respectively (approximated over the three carbon sources). The consensus motifs
and their positions are indicated for each factor. (B) Consensus motifs based on the top 30 peak intensities from the tiling array for Gal4p and Tye7p
on glucose media. The sequence surrounding the peak point (covering 5 probes, 300 bp) for each target was sent to MEME (http://meme.sdsc.edu/
meme4/) and the most significant motif (Gal4p: E=9.3E-24; Tye7p: E=1.8E-15) is reported.
doi:10.1371/journal.ppat.1000612.g007
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genes are known to be up-regulated in response to hypoxia in C.
albicans [39], we tested the ability of our deletion strains to grow in
oxygen-limiting environments. The gal4 strain was unaffected but
the tye7 and gal4tye7 strains displayed a severe growth defect
(Figure 8A). This defect was observed not only at 30uC but also at
37uC, the human physiological temperature (Figure S5A). This is
further validation for Gal4p and Tye7p’s role in fermentative
metabolism.
To confirm that Tye7p is responsible for the induction of the
glycolytic genes under hypoxic conditions we repeated the
expression profile under glucose growth conditions in the presence
of nitrogen instead of oxygen (for complete lists see Tables S14 and
S15). As observed under oxygen rich (normoxic) growth
conditions, the glycolytic genes were down-regulated (Figure 8B
and Table S7). However, there were some differences compared to
the normoxia profile. First, some metabolic genes altered their
expression to adjust to the low oxygen environment in the absence
of the key glycolytic activator. These changes include the up-
regulation of gluconeogenesis-specific genes, glycerol synthesis
genes, pentose phosphate pathway genes, and the PDH genes, all
of which were either down-regulated or not significantly regulated
in the normoxia profile. The lack of a fully functional glycolytic
pathway would result in gluconeogenesis stimulation, glycerol
synthesis is an alternative to ethanol fermentation to regenerate
NAD+, the pentose phosphate pathway is an alternative to
glycolysis to generate reducing equivalents, and increasing PDH
expression would promote respiration for any of the available
pyruvate. Second, GAL4 expression was significantly up-regulated
(5.5 fold compared to 1.4 fold in normoxic conditions). This up-
regulation also explains the increase in PDH expression and is
likely why some glycolytic genes were not as significantly down-
regulated. Third, the expression of many more genes was altered
in the hypoxia profile, but many of these could be attributed to the
significant growth defect of the tye7 strain (doubling time was
approximately 220 min compared to the wild type at around
110 min). We chose to just focus on the effect on metabolic gene
expression as we had already established Tye7p as a metabolic
regulator under normoxic conditions.
Based on the reduced growth rate of the gal4tye7 strain
compared to the tye7 strain in low oxygen growth conditions, we
assumed that Gal4p was also involved in the induction of the
glycolytic genes. The expression profile with the gal4tye7 strain was
not done due to the severe growth defect. However, to confirm our
hypothesis we transferred normoxia grown cultures to low oxygen
conditions for 30 min and analyzed glycolytic gene expression by
qPCR. The gal4tye7 strain showed a significant further down-
regulation compared to the tye7 strain (Figure 8C).
To ensure our hypoxia experimental set-up was accurate and
that the glycolytic genes were induced, we compared the wild type
strain under hypoxic and normoxic conditions (Figure 8B and
Table S7). Our results agreed well with previously published data
[39] as glycolytic, fermentation, stress response, cell wall, fatty
acid, iron metabolism, and hyphae-specific genes were up-
regulated while TCA cycle, respiration, and ATP-synthesis genes
were down-regulated (for complete lists see Tables S16 and S17).
Surprisingly, TYE7 and GAL4 expression appeared down-
regulated in the wild type under hypoxia. Recently, it has been
shown that the glycolytic genes can be rapidly induced under
hypoxia before subsequently declining [40]. This dynamic
expression is especially true for transcription factors that must be
quickly up-regulated to activate their target genes but may become
down-regulated once their target genes have reached their needed
expression levels. Therefore, we measured the levels of TYE7,
GAL4, and the glycolytic gene CDC19 at four different time points
following a shift to hypoxic growth conditions (Figure S6). We
observed a rapid increase in TYE7 and GAL4 expression in the first
15 minutes followed by a sharp decline. In contrast, CDC19
induction was longer and the decline less drastic. Thus, TYE7 and
GAL4 are initially induced by hypoxia to activate the glycolytic
genes before they are subsequently down-regulated.
Complete glycolytic activation by Gal4p and Tye7p is
required for full virulence
Since metabolic flexibility and growth under low oxygen
conditions are important for pathogens, we investigated the effect
of deleting GAL4 and TYE7 on the virulence of C. albicans.W e
chose to first test all of our strains using the greater wax moth
Galleria mellonella as a host model. Screening the virulence of C.
albicans strains in Galleria has been shown to produce similar results
to those measured through systemic infections with mice [41]. As
controls, injections of PBS or UV/heat-killed BWP17 did not kill
any Galleria over seven days, demonstrating that any death was
attributable to viable C. albicans cells. The gal4 strain showed a
minor, but significant (P=0.008, log-rank test) difference com-
pared to the wild type, while both the tye7 and gal4tye7 strains
showed very significant (P,0.0001, log-rank test) attenuated
virulence (Figure 9). These results correlate with the observed
growth defects under hypoxic conditions. If the mutant strains
grow slower than the wild type due to a lower oxygen environment
inside the insect, the insect is able to survive for a longer period of
time.
The double mutant strain was also tested in two mouse models,
A/J and C57BL/6J, to support the result from the Galleria model
and allow for further analysis. The A/J strain is C5 deficient and is
highly sensitive to systemic infection with C. albicans while the
C57BL/6J strain is C5 sufficient and therefore is less sensitive [42].
As with the Galleria model, the gal4tye7 strain displayed significant
attenuated virulence in both A/J (P=0.0009, log-rank test) and
C57BL/6J (P=0.0007) mouse models (Figure 10A).
Fungal loads from different tissues were examined. For the A/J
mice, two sets of six mice were injected with the gal4tye7 strain.
Fungal loads for the first set were determined 24 hours after
injection, when the mice challenged with the wild type and
revertant strains were euthanized due to moribundity. Fungal
loads from the kidney, liver, and heart were significantly lower
(P=0.002, 0.002, and 0.009, respectively, Mann-Whitney test) in
the gal4tye7 infected mice compared to mice challenged with the
wild type strain (Figure 10B and Table 2). The fungal load of the
second set was determined when the gal4tye7 infected mice became
moribund. The fungal burden of this set showed comparable levels
to the mice injected with the wild type strain (Figure 10B and
Table 2). For the C57BL/6J mice, kidney fungal loads were
determined following euthanization due to moribundity or survival
until day 21. Five of the six C57BL/6J mice challenged with the
gal4tye7 strain survived until day 21 and four of them completely
cleared the infection (Figure 10B).
Histological examination showed in vivo hyphae formation of the
mutant strain in the kidney of A/J mice (Figure 10C) and
confirmed the observations that the gal4tye7 strain is able form
hyphae in the presence of serum, N-acetylglucosamine, and spider
media in vitro (data not shown). These results further support the
hypothesis that the reduced virulence of the double mutant strain
is attributed to a growth defect due to low oxygen environments in
the host, which allows the organism to survive with the infection
for a longer time and increases the chance the host’s immune
system is able to clear the infection.
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PLoS Pathogens | www.plospathogens.org 11 October 2009 | Volume 5 | Issue 10 | e1000612Figure 8. TYE7 and GAL4 are important for hypoxic growth and the induction of glycolytic genes in a low oxygen environment. (A)
Cells were serially diluted, plated on YPD, and incubated in an anaerobic chamber at 30uC for 4 days. The chamber was flushed daily with nitrogen.
Due to the space limitation of the chamber, the revertant strains were unable to be spotted on the same plate. A second experiment including the
revertant strains was done on two separate plates to verify the results (Figure S5B). (B) Heat map displays were created as described in Figure 4.
Transcription profiles of selected metabolic genes for (from left to right) BWP17 hypoxia relative to BWP17 normoxia, tye7 hypoxia relative to BWP17
hypoxia, and tye7 normoxia relative to BWP17 normoxia. The expression levels of these and other metabolic genes are given in Table S7. (C) The
expression levels of several glycolytic genes were measured by qPCR in the tye7 and gal4tye7 strains relative to the wild type (BWP17) after 30 min of
growth under hypoxic conditions. ACT1 was used as the reference.
doi:10.1371/journal.ppat.1000612.g008
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Although fungi generally have similarly designed metabolic
pathways, their transcriptional regulation of these pathways can be
quite different, as illustrated by the human fungal pathogen C.
albicans and the non-pathogenic yeast S. cerevisiae. Crabtree-positive
yeasts, such as S. cerevisiae, have developed a circuit that represses
the respiration pathway and up-regulates the glycolytic/fermen-
tation pathway in the presence of excess glucose even under
aerobic conditions. In contrast, C. albicans is Crabtree-negative and
prefers to completely oxidize carbohydrates through the respira-
tion pathway in aerobic conditions, only relying on the
fermentation pathway in the absence of oxygen. Furthermore, C.
albicans up-regulates the glycolytic pathway in low oxygen
conditions while S. cerevisiae does not [39]. These metabolic
responses of C. albicans are similar to the majority of fungi and
other eukaryotes. Therefore, it is important to extend our
understanding of transcriptional control of carbohydrate metab-
olism beyond S. cerevisiae to other organisms.
Although the glycolytic transcriptional circuit has been studied
in the yeast Kluyveromyces lactis [19,43], which lacks the glucose
repression circuit, this organism is closely related to S. cerevisiae and
its glycolytic genes are mainly regulated by orthologs of Gcr1p and
Gcr2p. It appears that K. lactis is an intermediate between S.
cerevisiae and the majority of aerobic fungi that do not contain
GCR1/2 homologs and therefore it is not a representative model of
Crabtree-negative fungi. We characterized Tye7p and Gal4p, two
transcriptional activators of the glycolytic pathway in C. albicans,
which lacks GCR1/2 homologs. Deleting both factors resulted in a
severe growth defect during culture on several fermentable carbon
sources (glucose, fructose, and mannose) when respiration was
inhibited or oxygen was limited; the single mutant gal4 strain
showed no growth defects while the tye7 strain displayed a slight
growth defect under these conditions. All deletion strains grew at
near wild type levels on a non-fermentable carbon source or with
fermentable sources when the respiration pathway was not
disrupted.
ChIP-CHIP and transcription profiling revealed that both
Tye7p and Gal4p are directly involved in the activation of the
entire glycolytic pathway. Tye7p bound all the glycolytic
promoters in a carbon source-independent manner and the tye7
strain showed a down-regulation of these genes that was most
significant in glucose growth conditions. Gal4p binding to the
promoter sequences of the glycolytic genes was affected by the
carbon source with a decrease in binding from glucose to galactose
to glycerol. Gal4p’s role in the activation of these genes was also
Figure 9. GAL4 and TYE7 are required for full virulence in a Galleria model. The survival curves for the indicated strains are shown. Each point
represents the average daily survival rate based on four replicates of 20 insects. The BWP17 and CMM1 survival curves were not significantly different
(P.0.05, log-rank test), demonstrating the limited effect of histidine and arginine auxotrophies.
doi:10.1371/journal.ppat.1000612.g009
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PLoS Pathogens | www.plospathogens.org 13 October 2009 | Volume 5 | Issue 10 | e1000612Figure 10. The gal4tye7 strain shows attenuated virulence in both A/J and C57BL/6J mouse models. (A) A/J (i) and C57BL/6J (ii) mice
were injected with either wild type (CAS8), gal4/gal4/tye7/tye7 (CAS9), or gal4/GAL4/tye7/TYE7 (CAS10) strains. A/J mice were monitored until
considered moribund while C57BL/6J were monitored over a 21 day period. The revertant strain was omitted from the A/J graph since all six mice
were euthanized on day 1 and would be masked by the wild type line. (B) (i) The kidney fungal load was determined 24 hours after injection for the
A/J mice. Mice infected with the gal4tye7 strain had approximately ten times less C. albicans cells than the mice challenged with either the wild type
or revertant strains. Another fungal load of gal4tye7 infected mice was determined upon moribundity and showed comparable levels to the mice
injected with the wild type strain after 24 hours. (ii) The kidney fungal load was determined upon euthanization of C57BL/6J mice when moribundity
was determined or mice survived until day 21. (C) Kidney sections of A/J infected mice were taken after euthanization and C. albicans cells were
revealed with the Grocott-Gomori methenamine-silver stain. Pictures shown are from tissue infected with the gal4tye7 strain indicating hyphal
formation. There was no obvious difference compared to sections taken from kidneys infected with wild type or revertant strains (data not shown).
doi:10.1371/journal.ppat.1000612.g010
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on glucose and galactose. Furthermore, transcription profiling and
qPCR confirmed that both Tye7p and Gal4p are involved in the
induction of the glycolytic genes under hypoxic growth conditions.
Gal4p and Tye7p also regulated metabolic processes linked to
the glycolytic pathway. Some of these roles are common while
some are independent of one another. Tye7p bound to and
activated many genes involved in trehalose and glycogen
metabolism without Gal4p’s involvement. As well, Tye7p strongly
activated the genes encoding phosphofructokinase, which catalyzes
an irreversible glycolytic-committing reaction. We showed that
deleting TYE7 increases the levels of trehalose and glycogen, likely
a result of the severely reduced glycolytic flux due to the extremely
low expression of PFK1 and PFK2. Deleting GAL4 had no effect on
the storage carbohydrate levels. Therefore, Tye7p has a role in
determining whether glucose is stored or utilized for energy
derivation, similar to Gcr1p in S. cerevisiae [44,45]. Coordinately
regulating this flux ensures that the cell is committed either to
storing energy or producing energy as to avoid futile cycling;
therefore, it is logical that the key glycolytic activator also regulates
trehalose and glycogen metabolism.
Another equilibrium that requires regulation is the flux between
fermentation and respiration. This flux depends on the competi-
tion for pyruvate between pyruvate decarboxylase (PDC) and the
pyruvate dehydrogenase complex (PDH) [46]. In S. cerevisiae,
glucose induces PDC expression to promote fermentation while
the PDH genes are unaffected and the TCA cycle is repressed
[21]. In A. oryzae and N. crassa, both the PDC and PDH are
induced by glucose and the TCA cycle is not repressed [28,29].
Increasing the transcription level of the PDH may be a mechanism
employed by Crabtree-negative cells to allow the PDH to out-
compete PDC, thereby increasing the respiratory capacity of the
cell. Both Gal4p and Tye7p bound to and activated the genes
involved in fermenting pyruvate to ethanol indicating that these
factors regulate the entire fermentation process from glucose to
ethanol. However, only Gal4p bound and activated the PDH
genes suggesting that it plays an important role in the metabolic
flux of the cell in directing respiration vs. fermentation modes.
Consequently, Gal4p has an indirect effect on the TCA cycle.
Although Gal4p did not bind the promoter sequences of the TCA
cycle genes in the ChIP-CHIP profile (except LSC1/2), deleting
GAL4 subsequently results in the down-regulation of the PDH
genes and ultimately several TCA cycle genes [34].
Therefore, although both Gal4p and Tye7p are key regulators
of the glycolytic pathway, each has its own distinct role. Tye7p is
the central transcriptional regulator of carbohydrate metabolism
that provides a strong basal level of glycolytic expression while
controlling the flux into the pathway and committing the cell to
glycolysis. Gal4p is a carbon source-dependent regulator that fine-
tunes gene expression based on the cells’ need for the fermentation
pathway. It assists Tye7p by increasing glycolytic gene expression
during growth on fermentable carbon sources. In the presence of
fermentable carbon sources Gal4p is able to significantly enhance
the energy producing part of the glycolytic pathway and promote
respiration by activating the PDH to meet the increased energy
needs of the cell and minimize the dependence on fermentation.
This assistance is not required with non-fermentable carbon
sources as the glycolytic flux is lower since gluconeogenesis is
stimulated and the cells grow at a slower rate with reduced energy
needs.
The most common types of antifungal drugs for C. albicans
infections, azoles, polyenes, and echinocandins, target cell
membrane and cell wall integrity; however, targeting fungal
metabolism could provide for future drug development. The
importance of glycolysis to C. albicans’ pathogenicity has been
shown as deleting CDC19 causes avirulence while a conditional
mutant of FBA1 results in attenuated virulence [3,4]. Since the
components of metabolic pathways are generally highly conserved,
orthologs exist in humans reducing interest in these functions as
potential drug targets (i.e. C. albicans CDC19 has approximately
50% amino acid identity with human pyruvate kinases). However,
Gal4p and Tye7p are fungal-specific regulators and therefore
represent potential antifungal targets. GAL4 and TYE7 were shown
to be important for the virulence in a Galleria and two mouse
models. This virulence effect is likely a result of a growth defect
due to the low oxygen conditions that are present in invasive
infections. The ability of two-thirds of the gal4tye7 injected
C57BL/6J mice to clear the infection highlights the real potential
of Gal4p and Tye7p as drug targets. Although the double mutant
strain did show significant attenuated virulence in all three host
models, it was not avirulent. This is likely attributed to the
metabolic flexibility of C. albicans and its ability to use alternative
carbon sources. The importance of alternative carbon metabolism
to C. albicans’ pathogenicity has been previously demonstrated as
deleting key enzymes of the glyoxylate cycle, gluconeogenesis, and
ß-oxidation pathways reduces virulence [3,47,48].
It appears that Gal4p and Tye7p have altered their function
throughout the evolution of fungi. We analyzed other genomes in
the Saccharomycotina subphylum and observed a pattern relating
the presence of GCR1/2 homologs and the clustering of the Gal4p
motif. Species that possess GCR1/2 homologs have an enrichment
of the Gal4p motif upstream of the GAL regulon genes while
species lacking GCR1/2 homologs have an enrichment of the
Gal4p motif in the promoter regions of the glycolytic genes.
Therefore, it appears that the rewiring of Gal4p coincides with the
loss/gain of GCR1/2, and that Gal4p and Tye7p likely regulate
glycolysis in the Saccharomycotina species lacking GCR1/2
homologs. Intriguingly, this rewiring event also appears to coincide
with changes in the galactose sensory network [49].
Along with the ribosomal transcriptional network [50,51], the
transcriptional regulatory control of glycolysis represents an
example of the plasticity of circuits throughout the evolution of
fungi. The Rap1p ribosomal circuit and the Gcr1p/Gcr2p
glycolytic circuit are unique to S. cerevisiae and closely related
species, suggesting that the transcriptional networks of S. cerevisiae
are not representative models of the fungal kingdom. However,
there is a key distinction between these two rewiring events. While
the regulatory components of the ribosomal network are different,
the ultimate outcome is identical. On the other hand, carbon
metabolism regulation is fundamentally different between Saccha-
romyces and other eukaryotes suggesting that the entire carbohy-
drate transcriptional network has undergone rewiring, not just the
regulators. Thus, investigating the regulation of carbon metabo-
Table 2. Fungal loads of selected tissues from A/J infected
mice.
Strain Mean burden (log CFU/organ)
Day 1 Day 2, 3, and 4
Kidney Liver Heart Kidney Liver Heart
WT 6.160.3 4.260.2 4.060.5 N/A N/A N/A
gal4/gal4/tye7/tye7 4.960.2 3.560.3 2.760.6 6.160.5 4.060.3 4.060.4
gal4/GAL4/tye7/TYE7 5.960.3 3.960.3 3.760.5 N/A N/A N/A
doi:10.1371/journal.ppat.1000612.t002
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extrapolated based on S. cerevisiae. This study thus defines the key
regulatory elements of glycolytic gene expression and provides
insights into the mode of transcriptional regulation of carbohy-
drate metabolism in a typical eukaryotic cell and a human
pathogen.
Materials and Methods
C. albicans strains and media
The C. albicans strains used in this study are listed in Table S18.
Cells were generally grown at 30uC in media containing 1% yeast
extract, 2% peptone, with either 2% dextrose (YPD), 2% galactose
(YPGal), or 2% glycerol (YPGly). All media was supplemented
with uridine (50 mg/ml).
Strain constructions
Plasmids and oligonucleotides used in this study are listed in
Tables S19 and S20, respectively. Gal4p and Tye7p were tagged
chromosomally with a TAP-URA3 PCR product [52]. Transfor-
mations were carried out using standard procedures [53]. Correct
integration of the TAP-tag was confirmed by PCR, and western
blots were used to verify protein expression.
BWP17 was used for generating the tye7 strain. CMM3 (gal4)
[34] was used to generate the gal4tye7 strain. The deletion and
complementation strains were created using the SAT1-flipper
cassette as described [54] with some modifications. The tye7
disruption construct was created by cloning 500 bp flanking
sequences of TYE7 into the plasmid pSFS2A. The plasmid was
linearized prior to transformation. Transformants were selected on
YPD plates containing 200 mg/ml of nourseothricin and con-
firmed by PCR. Excision was performed by incubation at 30uC for
5 hours in YP media with 2% maltose before plating on YPD
plates. Confirmation of excision events was done by PCR. The
process was repeated for disruption of the second allele. Revertants
of tye7 and gal4 were created using the gal4tye7 strain.
Complementation of tye7 was carried out by reintroducing the
ORF at its native locus by replacing the upstream flanking
sequence in the tye7 disruption cassette with the complete TYE7
ORF. A complementation cassette that consisted of the complete
GAL4 ORF and a 500 bp downstream flanking sequence was
constructed for reintroduction of GAL4 at its native locus. We
selected clones that replaced the HIS1 deletion cassette and then
restored histidine prototrophy by transformation with NruI-
digested pGEM-HIS1 [55].
CMM3 and CMM1 (wild type prototrophic equivalent of
CMM3) [34] were also used in the phenotypic assays. In all assays
BWP17 and CMM1 were used as control strains but they usually
gave identical results so only one was generally shown. The
exception was for the liquid growth curves as BWP17 plateaued at
a lower OD600 than CMM1. In this case, the tye7 strain was
compared to BWP17 and normalized to CMM1 for graphical
purposes.
As uridine auxotrophy affects virulence but can be restored by
integration of URA3 at the RPS10 locus [56], for the mouse studies
the CMM1, gal4/gal4/tye7/tye7, and gal4/GAL4/tye7/TYE7 strains
were made prototrophic by targeting the URA3 marker to the
RPS10 locus through StuI digestion of CIp10. Correct integration
was confirmed by PCR and qPCR verified that only one copy of
URA3 was integrated.
Phenotypic assays
Serial spotting plate assays were carried out as described [57]
except cells were washed twice with sterile water before plating.
Cells were plated on synthetic complete media containing the
carbon source at 0.2% or 2% and agarose at 2% to minimize
carbon source impurities. Antimycin A (2 mg/ml) was added to
inhibit respiration. For liquid assays, cells were grown to log phase
in synthetic medium with 5% glycerol, washed twice with sterile
water, and resuspended at an OD600=0.1 in synthetic media
containing the carbon source at 2%. Cells were either grown at
30uC in flasks with shaking (aerobic conditions) or in microtiter
plates without shaking (static conditions). Samples were done in
triplicate and the average was used for analysis. For growth under
hypoxic conditions, cells were spotted on YPD plates and
incubated in an anaerobic chamber. The chamber was flushed
daily with nitrogen to remove oxygen and any by-products.
ChIP-CHIP analysis
ChIP experiments were performed as previously described [52]
with some modifications. Briefly, cells were grown to OD600=2in
40 ml of YPD, YPGal, or YPGly. Tagged ChIPs were labeled with
Cy5 dye and untagged (mock) ChIPs were labeled with Cy3 dye.
Microarray hybridization and washing were performed as
described [58]. Scanning was done with a ScanArray Lite
microarray scanner (Perkin Elmer). QuantArray was used to
quantify fluorescence intensities. Data handling and analysis were
carried out using Genespring v.7.3 (Agilent Technologies). The
significance cut-off was determined using the distribution of log-
ratios for each factor. A minimum of three biological replicates
were analyzed for each carbon source condition with hybridization
to single spot full-genome (ORF and intergenic) microarrays
containing 11,817 70-mer oligonucleotide probes [52]. For
determining the number of targets and GO analysis with the
single probe microarrays, the cut-off was a fold enrichment .1.5
and a t-test P-value,0.1.
One replicate of the ChIP-CHIP experiments for each carbon
source condition was hybridized to a custom designed whole-
genome tiling array for further analysis. Using the C. albicans
Genome Assembly 21 [59] and the MTL alpha locus [60], we
extracted a continuous series of 242,860 60 bp oligonucleotides
each overlapping by 1 bp. We eliminated 2062 probes containing
stretches of at least 13 A/T nucleotides. The remaining 240,798
probes were used to produce a whole-genome tiling array using
the Agilent Technologies eArray service (https://earray.chem.
agilent.com/erray/).
Tiling array data processing and peak detection
Lowess normalization of the intensity ratio of each of the
240,798 probes was done using an in-house software implemen-
tation. The signal along each chromosome was smoothed using a
median filter (n=3) followed by a Gaussian low-pass filter
(s=150 bp). For peak localization, the smoothed signal was
interpolated at 10 bp intervals using cubic-spline resampling.
Peaks were reported in decreasing order of the smoothed
intensities.
RNA extraction and transcription profiles
RNA was extracted with the RNeasy Kit (Qiagen) as per
manufacturer’s instructions. Briefly, cells were grown to
OD600=0.8 in YPD, YPGal, or YPGly in aerated flasks
(normoxia) and disrupted using acid washed glass beads.
Transcriptional profiling was carried out as described [58] with
20 mg of RNA used for cDNA synthesis. A minimum of three
biological replicates on double spotted ORF microarrays (6,394
intragenic 70-mer oligonucleotide probes) were used for analysis
[58]. Scanning and analysis were carried out as described for
ChIP-CHIP except scanning was performed at two different laser
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transcripts including several glycolytic genes. For GO analysis and
the supplementary complete lists the cut-off was a difference in
expression .1.5 or ,0.67 and a t-test P-value,0.05.
Expression profiles under hypoxic conditions were performed as
described above except bottles containing YPD media were
flushed with nitrogen to remove oxygen. Two biological replicates
were performed and statistical analysis was done as with normoxic
conditions.
For qPCR analysis of glycolytic gene expression under hypoxic
conditions, BWP17, tye7, and gal4tye7 cultures were grown to
OD600=0.7 in YPD in an aerated flask. The cultures were then
transferred to bottles flushed with nitrogen and grown for an
additional 30 min before the RNA was extracted as above and
analyzed by qPCR.
For hypoxic induction kinetic analysis, BWP17 was grown to
OD600=0.8 in YPD in an aerated flask. Half the culture was
transferred to bottles flushed with nitrogen while the other half was
left to grow in the aerated flask. At different time points the RNA
was extracted and compared by qPCR.
qPCR analysis
For qPCR, cDNA was synthesized from 5 mg of total RNA
using the reverse-transcription system (50 mM Tris-HCl, 75 mM
KCl, 5 mM DTT, 3 mM MgCl2, 400 nM oligo(dT)15,1 mM
random octamers, 0.5 mM dNTPs, 200 units Superscript III
reverse transcriptase; Invitrogen). The mixture was incubated for
60 min at 50uC. Aliquots were used for qPCR, which was
performed using the Corbett Rotor-Gene RG3000A (Corbett
Research) with SYBR Green fluorescence (Qiagen). Cycling was
10 min at 95uC followed by 40 cycles (95uC, 10 s; 58uC, 15 s;
72uC, 20 s). Samples were done in triplicate and means were used
for calculations. Fold changes were estimated using the compar-
ative DDCt method as described [61] with the coding sequence of
the C. albicans ACT1 ORF as a reference.
Measuring trehalose and glycogen levels
Trehalose levels were measured as based on previous studies
[62]. Briefly, cells were either grown to log phase (OD600=2)or
grown for 40 hours to reach stationary phase, washed twice with
cold water, and resuspended in water. Cells were lysed by
incubating at 95uC for 30 min and the supernatant was used for
enzymatic analysis. Reactions (50 mlo fs a m p l e ,1 0 0ml2 7 0m M
citric acid buffer pH 5.7, and 0.15 U trehalase (Sigma)) were
incubated at 37uC for 5 hours. Glucose amounts were assayed
with the hexokinase glucose kit (Sigma) with endogenous glucose
levels determined based on reactions without trehalase. A BCA
protein assay (Pierce) was performed as per manufacturer’s
instructions. Relative trehalose levels were based on nmol
trehalose per mg of cell protein. Three biological replicates were
performed for each strain and condition. Glycogen levels were
estimated using the iodine vapor method [63]. Cells were serially
diluted, spotted on YPD plates, and incubated for 24 hours
at 30uC. The cells were then exposed to iodine vapor for 5
minutes.
Measuring protein expression levels
To determine the protein expression of Gal4p and Tye7p under
different carbon sources, overnight cultures in YPD were diluted
to OD600=0.4 and grown for 2 hours in fresh YPD. Cells were
washed twice with sterile water and resuspended in YP, YPD,
YPGal, or YPGly media and grown for an additional 3 hours. The
cells were then washed with TBS buffer and lysed using acid
washed glass beads (same lysis buffer as ChIP-CHIP except for
addition of a phosphatase inhibitor cocktail (Roche)). The protein
extract was clarified by centrifugation and a BCA protein assay
(Pierce) was performed as per manufacturer’s instructions. Gal4p
and Tye7p were separated on a 10% SDS gel and transferred to a
PVDF membrane. A rabbit polyclonal antibody directed against
the TAP-tag (Open Biosystems) was used (1:2000 dilution). A
mouse anti-actin monoclonal antibody (1:500 dilution, Chemicon)
was used to probe actin as a loading control. HRP-conjugated
anti-rabbit and anti-mouse secondary antibodies (Santa Cruz)
were used (1:10,000 dilution). The HRP signal was revealed using
the Lumi-Light Western Blotting Substrate (Roche).
Virulence studies
For Galleria mellonella studies, overnight cultures were washed
twice with PBS and resuspended in PBS at OD600=8. Larvae, in
the final instar, weighing 180610 mg were injected between the
third pair prothoracic legs with 10 ml of suspension (8610
5 cells).
Infected larvae were incubated at 37uC in the dark with excess of a
multigrain diet supplemented with glycerol and vitamins [64].
Four replicates, each consisting of 20 insects, were carried out with
survival rates measured daily for a period of 7 days. Death was
determined based on the lack of response to touch and the inability
to right themselves. A BWP17 culture was irradiated with UV for
2 hours and incubated at 95uC for 1 hour before injection to
confirm that viable C. albicans cells were responsible for death.
Kaplan-Meier survival curves were created and compared with
the log-rank test (GraphPad Prism 5).
Mouse studies were carried out as previously described [65].
Briefly, 8–12 week-old A/J and C57BL/6J mice (Jackson
Laboratories, Bar Harbor, ME) were inoculated via the tail vein
with 200 ml of a suspension containing 3610
5 C. albicans in PBS.
Six mice, three female and three male, were used for each
experimental group except for the gal4tye7 injected A/J set where
six females and six males were used. Mice were closely monitored
and those showing extreme lethargy were considered moribund
and were euthanized. Target organs were removed aseptically and
homogenized in PBS before plating on YPD plates containing
chloramphenicol (34 mg/ml). The number of yeast colonies per
organ was determined, log-transformed, and compared using the
Mann-Whitney test (GraphPad Prism 5). Comparative genomic
hybridization (CGH) analysis was performed on all strains prior to
injection to verify that no aneuploidy arose as a result of any of the
genetic manipulations. All experimental procedures involving mice
were approved by the Biotechnology Research Institute Animal
Care Committee, which operated under the guidelines of the
Canadian Council of Animal Care.
Supporting Information
Figure S1 Liquid assays verify that GAL4 and TYE7 are involved
in fermentative growth with glucose, fructose or mannose as the
carbon source. WT refers to strain CMM1. (A) Growth curves
where strains were grown with aeration. (B) Growth curves where
strains were grown without aeration.
Found at: doi:10.1371/journal.ppat.1000612.s001 (1.30 MB PDF)
Figure S2 Overlap of binding targets for Gal4p and Tye7p
under glucose, galactose, and glycerol growth conditions. Peaks
common to all three carbon sources had peak intensities .2f o l d
in all three conditions with the tiling array data. A peak was
consideredtobeuniquetoa carbon source(or sources)if thepeak
intensity in the condition (or conditions) was .2f o l da n dt h e
peak intensities in the remaining carbon sources were ,1.4 fold.
This result confirms that for most targets Gal4p displays carbon-
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stitutive.
Found at: doi:10.1371/journal.ppat.1000612.s002 (0.53 MB PDF)
Figure S3 Both Gal4p and Tye7p are induced by glucose but
Tye7p has a higher constitutive expression. Protein expression
levels of Gal4p and Tye7p under different carbon sources are
presented. YP media with no additional carbon source was
included to establish the basal level of expression. Actin was used
as the loading control.
Found at: doi:10.1371/journal.ppat.1000612.s003 (0.24 MB PDF)
Figure S4 qPCR validation of transcription profile results under
oxygen rich growth conditions. Expression levels for HXK2 (A),
CDC19 (B), and TDH3 (C) were determined in tye7 and gal4tye7
strains relative to the wild type (BWP17) under normoxic growth
conditions. ACT1 was used as the reference. TDH3 was included
since its expression was unchanged according to the transcription
profiles despite being bound by Gal4p and Tye7p (Figure 6A);
however, qPCR showed that TDH3 is indeed activated by Gal4p
and Tye7p. We later discovered that there was a spotting problem
with the TDH3 probe for the particular set of microarrays used
and therefore we omitted the gene from the expression profile heat
map displays in Figures 4B, 6B, and 8B.
Found at: doi:10.1371/journal.ppat.1000612.s004 (0.30 MB PDF)
Figure S5 GAL4 and TYE7 are important for hypoxic growth
at both 30uCa n d3 7 uC. (A) Strains were serially diluted on YPD
plates and incubated in an anaerobic jar at 37uCf o r2d a y s .W T
refers to strain CMM1. (B) Strains were serially diluted on two
separate YPD plates and incubated in an anaerobic jar at 30uC
for 4 days. One representative dilution is shown. The WT for
the top row is CMM1 and the WT for the bottom row is
BWP17. One copy of either GAL4 or TYE7 is able to restore the
growth defect of the double mutant strain although the GAL4
revertant does not grow at wild type levels since TYE7 is still
deleted.
Found at: doi:10.1371/journal.ppat.1000612.s005 (1.67 MB PDF)
Figure S6 GAL4 and TYE7 are initially induced by hypoxia. The
expression levels of GAL4, TYE7, and CDC19 were measured in
BWP17 by qPCR at different time points following a shift from
normoxic to hypoxic growth conditions. ACT1 was used as the
reference.
Found at: doi:10.1371/journal.ppat.1000612.s006 (0.57 MB PDF)
Table S1 Doubling times under fermentative growth conditions.
Found at: doi:10.1371/journal.ppat.1000612.s007 (0.02 MB XLS)
Table S2 Gal4p ChIP-CHIP targets with glucose as the carbon
source.
Found at: doi:10.1371/journal.ppat.1000612.s008 (0.03 MB XLS)
Table S3 Tye7p ChIP-CHIP targets with glucose as the carbon
source.
Found at: doi:10.1371/journal.ppat.1000612.s009 (0.05 MB XLS)
Table S4 Top Gal4p YPD binding peaks with tiling array.
Found at: doi:10.1371/journal.ppat.1000612.s010 (0.02 MB XLS)
Table S5 Top Tye7p YPD binding peaks with tiling array.
Found at: doi:10.1371/journal.ppat.1000612.s011 (0.02 MB XLS)
Table S6 ChIP-CHIP binding enrichments of selected meta-
bolic genes under different carbon sources.
Found at: doi:10.1371/journal.ppat.1000612.s012 (0.03 MB XLS)
Table S7 Expression levels of selected metabolic genes for tye7
and gal4tye7 strains under different carbon sources and oxygen
levels.
Found at: doi:10.1371/journal.ppat.1000612.s013 (0.03 MB XLS)
Table S8 Genes down-regulated in tye7 strain in glucose growth
conditions.
Found at: doi:10.1371/journal.ppat.1000612.s014 (0.03 MB XLS)
Table S9 Genes down-regulated in gal4tye7 strain in glucose
growth conditions.
Found at: doi:10.1371/journal.ppat.1000612.s015 (0.03 MB XLS)
Table S10 Genes down-regulated in tye7 strain in galactose
growth conditions.
Found at: doi:10.1371/journal.ppat.1000612.s016 (0.02 MB XLS)
Table S11 Genes down-regulated in gal4tye7 strain in galactose
growth conditions.
Found at: doi:10.1371/journal.ppat.1000612.s017 (0.04 MB XLS)
Table S12 Genes down-regulated in tye7 strain in glycerol
growth conditions.
Found at: doi:10.1371/journal.ppat.1000612.s018 (0.03 MB XLS)
Table S13 Genes down-regulated in gal4tye7 strain in glycerol
growth conditions.
Found at: doi:10.1371/journal.ppat.1000612.s019 (0.03 MB XLS)
Table S14 Genes down-regulated in tye7 strain in glucose
hypoxic growth conditions.
Found at: doi:10.1371/journal.ppat.1000612.s020 (0.07 MB XLS)
Table S15 Genes up-regulated in tye7 strain in glucose hypoxic
growth conditions.
Found at: doi:10.1371/journal.ppat.1000612.s021 (0.05 MB XLS)
Table S16 Genes down-regulated in BWP17 strain in glucose
hypoxic growth conditions.
Found at: doi:10.1371/journal.ppat.1000612.s022 (0.04 MB XLS)
Table S17 Genes up-regulated in BWP17 strain in glucose
hypoxic growth conditions.
Found at: doi:10.1371/journal.ppat.1000612.s023 (0.05 MB XLS)
Table S18 Strains used in this study.
Found at: doi:10.1371/journal.ppat.1000612.s024 (0.03 MB XLS)
Table S19 Plasmids used in this study.
Found at: doi:10.1371/journal.ppat.1000612.s025 (0.02 MB XLS)
Table S20 Primers used in this study.
Found at: doi:10.1371/journal.ppat.1000612.s026 (0.02 MB XLS)
Dataset S1 ChIP-CHIP normalized tiling array data. Columns
correspond to (L to R) Tye7p YPD, YPGal, YPGly; Gal4p YPD,
YPGal, YPGly. The start (.) and end (|) of each ORF is
indicated. Values given for each probe are log2 (fold enrichment)
with negative values indicating enrichment for Gal4p or Tye7p
binding. Significant binding events are highlighted in green.
Found at: doi:10.1371/journal.ppat.1000612.s027 (3.52 MB ZIP)
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